Back to results
US 12,215,326 B2Granted
RNA-targeting system
AssigneesThe Broad Institute, Inc., Massachusetts Institute of Technology, President and Fellows of Harvard College
InventorsFeng Zhang, Patrick Hsu, Jonathan S. Gootenberg, Aaron Smargon
Life of this patent
Estimating the term…
Abstract
The invention provides for systems, methods, and compositions for targeting RNA. In particular, the invention provides a non-naturally occurring or engineered RNA-targeting system comprising an RNA-targeting Cas protein and at least one RNA-targeting guide RNA, wherein said RNA-targeting guide RNA is capable of hybridizing with a target RNA in a cell.
Claims36
A non-naturally occurring or engineered vector system comprising one or more vectors comprising:
- a) a first regulatory element operably linked to a first polynucleotide sequence encoding an RNA-targeting guide RNA (Rt-gRNA), wherein said Rt-gRNA is designed to hybridize with a target RNA, wherein said Rt-gRNA comprises:
- (i) a small CRISPR/Cas system associated RNA (scaRNA) sequence, and
- (ii) a trans-activating CRISPR/Cas system RNA (tracrRNA) sequence, wherein said scaRNA and said tracrRNA are designed to at least partially hybridize to each other, and
- b) a second regulatory element operably linked to a second polynucleotide sequence encoding
- (i) a Francisella novicida Cas protein (FnCas) or ortholog, homolog, or fragment thereof comprising a Rec1 domain, Rec2 domain, HNH domain, and PAM Interacting (PI) domain, and
- (ii) one or more heterologous functional domains positioned at one or more sites in FnCas that are analogous to amino acid positions 534-676 corresponding to a wild type Streptococcus pyogenes Cas9 (SpCas9) Rec1 domain
- wherein the Rt-gRNA is capable of forming an RNA-targeting complex with the FnCas and of directing sequence-specific binding of the RNA-targeting complex to the target RNA,
- wherein each of the one or more heterologous functional domains comprise one or more of the following activities:
- methylase activity, demethylase activity, translation activation activity, translation repression activity, histone modification activity, RNA cleavage activity, or DNA cleavage activity, and
- wherein components (a) and (b) are located on the same or different vectors of the system and wherein the Rt-gRNA and said FnCas protein do not naturally occur together.
7 more elements
Dependencies are inferred from the claim text.